159
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Safety assessment of a calcium-potassium salt of (−)-hydroxycitric acid

, , , , &
Pages 515-525 | Received 28 Jun 2010, Accepted 27 Aug 2010, Published online: 14 Oct 2010

References

  • Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J. 2006. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res 98:490–498.
  • Boll PM, Sorensen E, Balieu E. 1969. Naturally occurring lactones and lactames. The absolute configuration of the hydroxycitric acid lactone: Hibiscus acid and Garcinia acid. Acta Chem Scand 23:286–293.
  • Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN. 2006. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126:321–334.
  • Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM. 2001. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113–1121.
  • Dannewitz B, Edrich C, Tomakidi P, Kohl A, Gabbert O, Eickholz P, Steinberg T. 2006. Elevated gene expression of MMP-1, MMP-10, and TIMP-1 reveal changes of molecules involved in turn-over of extracellular matrix in cyclosporine-induced gingival overgrowth. Cell Tis Res 325:513–522.
  • Dara L, Hewett J, Lim JK. 2008. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 14:6999–7004.
  • Deshmukh NS, Bagchi M, Yasmin T, Bagchi D. 2008a. Safety of a novel calcium/potassium saltof (-)-hydroxycitric acid (HCA-SX): II. Developmental toxicity study in rats. Toxicol Mech Met 18:443–451.
  • Deshmukh NS, Bagchi M, Yasmin T, Bagchi D. 2008b. Safety of a novel calcium/potassium salt of hydroxycitric acid (HCA-SX): I. Two-generation reproduction toxicity study. Toxicol Mech Met 18:433–442.
  • Downs BW, Bagchi M, Subbaraju GV, Shara MA, Preuss HG, Bagchi D. 2005. Bioefficacy of a novel calcium-potassium salt of (-)-hydroxycitric acid. Mutat Res 579:149–162.
  • FDA – US Food and Drug Administration. Generally Recognized as Safe (GRAS). Available online at: http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/default.htm, accessed July 2010.
  • Figueroa J, Vijayagopal P, Debata C, Prasad A, Prasad C. 1999. Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice. Life Sci 64:1339–1347.
  • Friedman JM. 1998. Leptin, leptin receptors, and the control of body weight. Nut Rev 56:38–46.
  • Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395:763–770.
  • Fuller RW, Wong DT, Robertson DW. 1991. Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev 11:17–34.
  • Garcia A, Sekowski A, Subramanian V, Brasaemle DL. 2003. The central domain is required to target and anchor perilipin A to lipid droplets. J Biol Chem 278:625–635.
  • Gloerich J, Ruiter JP, van den Brink DM, Ofman R, Ferdinandusse S, Wanders RJ. 2006. Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation. FEBS Lett 580:2092–2096.
  • Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. 1999. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21:424–428.
  • Jones FJ, Andrews AH. 2007. Acute liver injury associated with the herbal supplement Hydroxycut in a soldier deployed in Iraq. Am J Gastroenterol 102:2357.
  • Kim BW, Choo HJ, Lee JW, Kim JH, Ko YG. 2004. Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp Mol Med 36:476–485.
  • Lau FC, Bagchi M, Sen C, Roy S, Bagchi D. 2008. Nutrigenomic analysis of diet-gene interactions on functional supplements for weight management. Curr Genomics 9:239–251.
  • Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW, Hammock BD, Couper DJ, Heiss G, Zeldin DC. 2006. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet 15:1640–1649.
  • Lijnen, H.R., Van, H.B., Frederix, L., Rio, M.C., Collen, D. 2002. Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity. Thromb Haemost. 87: 530–535.
  • Lin J, Handschin C, Spiegelman BM. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361–370.
  • Lingjaerde O, Kildemo O. 1981. Dopamine uptake in platelets: two different low affinity, saturable mechanisms. Agents Actions 11:410–416.
  • Loe YC, Bergeron N, Rodriguez N, Schwarz JM. 2001. Gas chromatography/mass spectrometry method to quantify blood hydroxycitrate concentration. Analyt Biochem 292:148–154.
  • Lobb A. 2009. Hepatotoxicity associated with weight-loss supplements: a case for better post-marketing surveillance. World J Gastroenterol 15:1786–1787.
  • Martin FW, Campbell CW, Rubertbe RM. 1987. Perennial edible fruits of the tropics: an inventory. USDA no. 642 1–125.
  • Maquoi E, Demeulemeester D, Voros G, Collen D, Lijnen HR. 2003. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 89:696–704.
  • Monjok EM, Kullkarni K, Mgbere O, Kouamou G, Ohia SE, Bagchi D, Bagchi M, Opere C. 2005. Regulation of rat brain neuropeptide Y concentration by hydroxycitric acid, in vitro. FASEB 19: Abtract. 310.8.
  • Mozersky DO, Klonz K, Katz LM. 2009. The problem: liver toxicity following consumption of dietary supplement, Hydroxycut. Health Hazard Review Board FDA 2009. Available online at: www.fda.gov/oc/opacom/hottopics/hydroxycut/HHE.pdf, accessed
  • Obunike JC, Sivaram P, Paka L, Low MG, Goldberg IJ. 1996. Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways. J Lipid Res 37:2439–2449.
  • Ohia SE, Awe O, LeDay AM, Opere CA, Bagchi D. 2001. Effect of hydroxycitric acid on serotonin release from isolated rat brain cortex. Res Commun Mol Pathol Pharmacol 109:210–216.
  • Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ. 2002. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem 238:89–103.
  • Preuss HG, Bagchi D, Bagchi M, Rao CV, Dey DK, Satyanarayana S. 2004b. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabet Obes Metabol 6:171–180.
  • Preuss HG, Bagchi D, Bagchi M, Rao CVS, Satyanarayana S, Dey DK. 2004c. Efficacy of a novel, natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX, niacin bound chromium and Gymnema sylvestre extract in weight management in human volunteers: a pilot study. Nutr Res24:45.
  • Preuss HG, Garis RI, Bramble JD, Bagchi D, Bagchi M, Rao CV, Satyanarayana S. 2005. Efficacy of a novel calcium/potassium salt of (−)-hydroxycitric acid in weight control. Int J Clin Pharmacol Res 25:133–144.
  • Preuss HG, Rao CV, Garis R. 2004a. An overview of the safety and efficacy of a novel, natural (−)-hydroxycitric acid extract (HCA-SX) for weight management. J Med 35:33–48.
  • Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, Enayetallah AE, Zeldin DC, Grant DF. 2003. Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64: 482–490.
  • Roy S, Rink C, Khanna S, Phillips C, Bagchi D, Bagchi M, Sen CK. 2004. Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement. Gene Expr 11:251–262.
  • Roy S, Shah H, Rink C, Khanna S, Bagchi D, Bagchi M, Sen CK. 2007. Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. DNA Cell Biol 26:627–639.
  • Sasaki K, Takagi M, Konttinen YT, Sasaki A, Tamaki Y, Ogino T, Santavirta S, Salo J. 2007. Upregulation of matrix metalloproteinase (MMP)-1 and its activator MMP-3 of human osteoblast by uniaxial cyclic stimulation. J Biomed Mater Res B Appl Biomater 80:491–498.
  • Schluter A, Yubero P, Iglesias R, Giralt M, Villarroya F. 2002. The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiation. Int J Obes Relat Metab Disord 26:1277–1280.
  • Sergio W. 1988. A natural food, the Malabar Tamarind, may be effective in the treatment of obesity. Med Hypotheses 29:39–40.
  • Shara M, Ohia SE, Schmidt RE, Yasmin T, Zardetto-Smith A, Kincaid A, Bagchi M, Chatterjee A, Bagchi D, Stohs SJ. 2004. Physico-chemical properties of a novel (-)-hydroxycitric acid extract and its effect on body weight, selected organ weights, hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological changes over a period of 90 days. Mol Cell Biochem 260:171–186.
  • Shara M, Ohia SE, Yasmin T, Zardetto-Smith A, Kincaid A, Bagchi M, Chatterjee A, Bagchi D, Stohs SJ. 2003. Dose- and time-dependent effects of a novel (-)-hydroxycitric acid extract on body weight, hepatic and testicular lipid peroxidation, DNA fragmentation and histopathological data over a period of 90 days. Mol Cell Biochem 254:339–346.
  • Shim M, Saab S. 2009. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 54:406–409.
  • Soni MG, Burdock GA, Preuss HG, Stohs SJ, Ohia SE, Bagchi D. 2004. Safety assessment of (−)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt. Food Chem Toxicol 42:1513–1529.
  • Stevens T, Qadri A, Zein NN. 2005. Two patients with acute liver injury associated with the use of the herbal weight-loss supplement Hydroxycut [letter]. Ann Intern Med 142:477–478.
  • Stohs SJ, Press HG, Ohia SE, Kaats GR, Keen CL, Williams LD, Bintock GA. 2010. Safety and efficacy of hydroxycitric acid derived from Garcinia cambogia- A literature review. HerbalGram. 85:58–63.
  • Sullivan AC, Hamilton JG, Miller ON, Wheatley VR. 1972. Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate. Arch Biochem Biophys 150:183–190.
  • Van Guilder GP, Hoetzer GL, Smith DT, Irmiger HM, Greiner JJ, Stauffer BL, DeSouza CA. 2005. Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab 289:807–813.
  • Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR, Jr Siscovick, DS, Fornage M. 2007. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis 190:26–34.
  • Westerberg R, Mansson JE, Golozoubova V, Shabalina IG, Backlund EC, Tvrdik P, Retterstol K, Capecchi MR, Jacobsson A. 2006. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J Biol Chem 281:4958–4968.
  • Westerberg R, Tvrdik P, Unden AB, Mansson JE, Norlen L, Jakobsson A, Holleran WH, Elias PM, Asadi A, Flodby P, Toftgard R, Capecchi MR, Jacobsson A. 2004. Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J Biol Chem 279:5621–5629.
  • Westerterp-Plantenga MS, Kovacs EM. 2002. The effect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int J Obes Relat Metab Disord 26:870–872.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.